Implementation of a formal sleep center–based screening protocol for primary aldosteronism in patients with obstructive sleep apnea
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronismEuropean Journal of Endocrinology, 2013
- The Effect of Continuous Positive Airway Pressure Treatment on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Sleep Medicine, 2012
- Resistant hypertension, obstructive sleep apnoea and aldosteroneJournal of Human Hypertension, 2011
- Changes in the Perceived Epidemiology of Primary HyperaldosteronismInternational Journal of Hypertension, 2011
- Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronismJournal of the Renin-Angiotensin-Aldosterone System, 2010
- Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary reportJournal of Human Hypertension, 2009
- Cardiovascular Outcomes in Patients With Primary Aldosteronism After TreatmentArchives of internal medicine (1960), 2008
- Effect of Nocturnal Nasal Continuous Positive Airway Pressure on Blood Pressure in Obstructive Sleep ApneaHypertension, 2007
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsJACC, 2006
- Screening for Primary Aldosteronism in Essential Hypertension: Diagnostic Accuracy of the Ratio of Plasma Aldosterone Concentration to Plasma Renin ActivityClinical Chemistry, 2005